Inventor · disambiguated record
Bing Lou Wong
Also filed as: WONG BING L · WONG BING LOU
35 granted patents·9 pending applications·180 citations·filing 1994–2023
96Inventor score
Files withWONG BING LOU11VISION GLOBAL HOLDINGS LTD7BIOPURE CORP5BILLION KING INT LTD4DRAGON VICTORY DEV LTD4
Top patents by PatentIndex Score
44 records- 0194US7932356B1Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical compositionWONG BING LOU·Filed 2010·Granted Apr 26, 2011·37 cites·19 claims
- 0292US7989593B1Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereofWONG BING LOU·Filed 2011·Granted Aug 2, 2011·24 cites·13 claims
- 0391US9814759B2Pharmaceutical composition comprising recombinant hemoglobin protein or subunit-based therapeutic agent for cancer targeting treatmentCHEER GLOBAL LTD·Filed 2015·Granted Nov 14, 2017·6 cites·25 claims
- 0489US8106011B1Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linkingWONG BING LOU·Filed 2011·Granted Jan 31, 2012·18 cites·12 claims
- 0589US8084581B1Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with a high temperature short time heat treatment apparatusWONG BING LOU·Filed 2011·Granted Dec 27, 2011·10 cites·10 claims
- 0687US9255262B2Albumin-binding arginine deminase and the use thereofVISION GLOBAL HOLDINGS LTD·Filed 2014·Granted Feb 9, 2016·7 cites·19 claims
- 0786US9066933B2Oral delivery for hemoglobin based oxygen carriersWONG BING LOU·Filed 2012·Granted Jun 30, 2015·8 cites·4 claims
- 0884US8742073B2Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereofWONG BING LOU·Filed 2011·Granted Jun 3, 2014·8 cites·10 claims
- 0982US11208631B1Dual-enzyme composition for preventing, treating and/or alleviating veisalgia and symptoms associated therewithALCOLEAR LTD·Filed 2021·Granted Dec 28, 2021·1 cites·7 claims
- 1082US8048856B1Treatment methods using a heat stable oxygen carrier-containing pharmaceutical compositionBILLION KING LTD·Filed 2011·Granted Nov 1, 2011·7 cites·7 claims
- 1181US9796970B1Production of high purity chondroitinase ABCADVANTEK SERUM LABORATORIES LTD·Filed 2017·Granted Oct 24, 2017·2 cites·20 claims
- 1276US9056098B2Hemoglobin-based oxygen carrier-containing pharmaceutical composition for cancer targeting treatment and prevention of cancer recurrenceVISION GLOBAL HOLDINGS LTD·Filed 2014·Granted Jun 16, 2015·3 cites·16 claims
- 1373US9803185B2Method for cancer targeting treatment and detection of arginine using albumin-binding arginine deiminase fusion proteinVISION GLOBAL HOLDINGS LTD·Filed 2015·Granted Oct 31, 2017·1 cites·14 claims
- 1473US9763889B2Oral delivery system for hemoglobin based oxygen carriersBILLION KING INT LTD·Filed 2016·Granted Sep 19, 2017·1 cites·15 claims
- 1573US9636404B2Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imagingVISION GLOBAL HOLDINGS LTD·Filed 2014·Granted May 2, 2017·2 cites·20 claims
- 1666US11795441B2Dual-enzyme composition for preventing, treating and/or alleviating veisalgia and symptoms associated therewithALCOLEAR LTD·Filed 2022·Granted Oct 24, 2023·0 cites·13 claims
- 1763US12215360B2Encapsulation of dual-enzyme composition for preventing, treating and/or alleviating veisalgia and symptoms associated therewithBING BIOTECH LTD·Filed 2023·Granted Feb 4, 2025·0 cites·12 claims
- 1863US10214738B2Production of high purity chondroitinase ABCADVANTEK SERUM LABORATORIES LTD·Filed 2018·Granted Feb 26, 2019·0 cites·9 claims
- 1961US11471514B1Dual-enzyme composition for preventing, treating and/or alleviating veisalgia and symptoms associated therewithALCOLEAR LTD·Filed 2021·Granted Oct 18, 2022·0 cites·13 claims
- 2061USRE47233EAlbumin-binding arginine deiminase and the use thereofVISION GLOBAL HOLDINGS LTD·Filed 2017·Granted Feb 12, 2019·0 cites·19 claims
- 2161US10036004B1Production of high purity chondroitinase ABCADVANTEK SERUM LABORATORIES LTD·Filed 2017·Granted Jul 31, 2018·0 cites·13 claims
- 2259US5618687AProduction of 7-amino cephalosporanic acid with D-amino oxidase and deacylaseBIOPURE CORP·Filed 1994·Granted Apr 8, 1997·7 cites·8 claims
- 2354US11564983B1Efficient expression system of SARS-CoV-2 receptor binding domain (RBD), methods for purification and use thereofBETAGEN SCIENT LIMITED·Filed 2022·Granted Jan 31, 2023·0 cites·14 claims
- 2454US9506925B2Specific biomarker set for non-invasive diagnosis of liver cancerDRAGON VICTORY DEV LTD·Filed 2014·Granted Nov 29, 2016·0 cites·5 claims
- 2554US2023256077A1Efficient expression system of sars-cov-2 receptor binding domain (rbd), methods for purification and use thereofBETAGEN SCIENT LIMITED·Filed 2022·Application pending·0 cites
- 2652US10620209B2Specific biomarker set for non-invasive diagnosis of liver cancerDRAGON VICTORY DEV LTD·Filed 2016·Granted Apr 14, 2020·0 cites·5 claims
- 2751US6594735B1High availability computing systemNORTEL NETWORKS LTD·Filed 1998·Granted Jul 15, 2003·28 cites·15 claims
- 2849US10322180B2Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imagingVISION GLOBAL HOLDINGS LTD·Filed 2017·Granted Jun 18, 2019·0 cites·4 claims
- 2949US9885718B2Specific biomarker set for non-invasive diagnosis of liver cancerDRAGON VICTORY DEV LTD·Filed 2014·Granted Feb 6, 2018·0 cites·2 claims
- 3049US2019249166A1Antidote for ChondroitinaseWONG BING LOU·Filed 2019·Application pending·0 cites
- 3148USRE48805EMethod for cancer targeting treatment and detection of arginine using albumin-binding arginine deiminase fusion proteinVISION GLOBAL HOLDINGS LTD·Filed 2019·Granted Nov 2, 2021·0 cites·14 claims
- 3248US5695951AChlorination of cephalexin with chloroperoxidase from Rathayibacter biopuresisBIOPURE CORP·Filed 1994·Granted Dec 9, 1997·3 cites·4 claims
- 3348US2013219829A1Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition and the use thereofBILLION KING INT LTD·Filed 2013·Application pending·0 cites
- 3447US2014106004A1Hemoglobin-based oxygen carrier-containing pharmaceutical composition for cancer targeting treatment and prevention of cancer recurrenceWONG BING LOU·Filed 2012·Application pending·0 cites
- 3545US9770490B2Oral delivery for hemoglobin based oxygen carriersBILLION KING INT LTD·Filed 2015·Granted Sep 26, 2017·0 cites·24 claims
- 3644US10052290B2Enteric-coated hemoglobin multiparticulate for oral delivery of hemoglobin based oxygen carriersBILLION KING INT LTD·Filed 2016·Granted Aug 21, 2018·0 cites·19 claims
- 3744US5939299AEnzymatic production of cefaclor from cephalexinBIOPURE CORP·Filed 1997·Granted Aug 17, 1999·4 cites·4 claims
- 3844US2020386761A1Specific biomarker set for non-invasive diagnosis of liver cancerDRAGON VICTORY DEV LTD·Filed 2020·Application pending·0 cites
- 3944US2013052232A1Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linkingWONG BING LOU·Filed 2011·Application pending·0 cites
- 4044US2011319858A1Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical compositions and the use thereofWONG BING LOU·Filed 2010·Application pending·0 cites
- 4143US5589354AHalogenation of cephalexin with haloperoxidase from Rathayibacter biopuresisBIOPURE CORP·Filed 1994·Granted Dec 31, 1996·3 cites·4 claims
- 4238US2007128693A1Method for the inactivation and removal of dengue virus from biological samplesADVANTEK SERUM LAB LTD 3 F·Filed 2005·Application pending·0 cites
- 4335US2011319332A1Treatment methods using a heat stable oxygen carrier-containing pharmaceutical compositionWONG BING LOU·Filed 2011·Application pending·0 cites
- 4430US5854054ARathayibacter biopuresis produces cephalosporin haloperoxidaseBIOPURE CORP·Filed 1996·Granted Dec 29, 1998·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Bing Lou Wong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →